Trial Profile
Total versus corrected body weight for dosage of sugammadex in morbidly obese patients
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 23 Feb 2018
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- Acronyms COVERTO
- 23 Feb 2018 New trial record